63 related articles for article (PubMed ID: 1974421)
1. Lipoprotein binding of crosslinked type III collagen aminopropeptide and fractions of its antigen in blood.
Bowness JM; Tarr AH
Biochem Biophys Res Commun; 1990 Jul; 170(2):519-25. PubMed ID: 1974421
[TBL] [Abstract][Full Text] [Related]
2. Transglutaminase-catalysed cross-linking: a potential mechanism for the interaction of fibrinogen, low density lipoprotein and arterial type III procollagen.
Bowness JM; Tarr AH; Wiebe RI
Thromb Res; 1989 May; 54(4):357-67. PubMed ID: 2569775
[TBL] [Abstract][Full Text] [Related]
3. Increased type III procollagen in serum and skin of patients with amyotrophic lateral sclerosis.
Ono S; Imai T; Takahashi K; Jinnai K; Shimizu N; Nagao K
Acta Neurol Scand; 1999 Dec; 100(6):377-84. PubMed ID: 10589797
[TBL] [Abstract][Full Text] [Related]
4. Serum type III procollagen propeptide levels in acromegalic patients.
Verde GG; Santi I; Chiodini P; Cozzi R; Dallabonzana D; Oppizzi G; Liuzzi A
J Clin Endocrinol Metab; 1986 Dec; 63(6):1406-10. PubMed ID: 2878008
[TBL] [Abstract][Full Text] [Related]
5. High serum levels of procollagen type III N-terminal amino peptide in patients with congenital heart disease.
Sugimoto M; Masutani S; Seki M; Kajino H; Fujieda K; Senzaki H
Heart; 2009 Dec; 95(24):2023-8. PubMed ID: 19666460
[TBL] [Abstract][Full Text] [Related]
6. Serum type III procollagen peptide levels in coronary artery disease (a marker of atherosclerosis).
Bonnet J; Garderes PE; Aumailley M; Moreau C; Gouverneur G; Benchimol D; Crockett R; Larrue J; Bricaud H
Eur J Clin Invest; 1988 Feb; 18(1):18-21. PubMed ID: 3130254
[TBL] [Abstract][Full Text] [Related]
7. Immunochemical properties of the aminopropeptide of procollagen type III.
Rohde H; Bruckner P; Timpl R
Eur J Biochem; 1983 Sep; 135(2):197-202. PubMed ID: 6192992
[TBL] [Abstract][Full Text] [Related]
8. [Measurement of serum type III procollagen aminopeptide with RIA-gnost PIIIP coated tube: changes in patients with various alcoholic liver diseases after abstinence].
Maruyama K; Okazaki I; Takagi T; Takahashi H; Okuyama K; Horie Y; Takagi S; Kohno H; Sato S; Ishii H
Kaku Igaku; 1992 Feb; 29(2):151-7. PubMed ID: 1564787
[TBL] [Abstract][Full Text] [Related]
9. Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis.
Teare JP; Sherman D; Greenfield SM; Simpson J; Bray G; Catterall AP; Murray-Lyon IM; Peters TJ; Williams R; Thompson RP
Lancet; 1993 Oct; 342(8876):895-8. PubMed ID: 8105167
[TBL] [Abstract][Full Text] [Related]
10. Serum procollagen-III-peptide level correlates with disease activity in myelofibrosis with myeloid metaplasia.
Barosi G; Costa A; Liberato LN; Polino G; Spriano P; Magrini U
Br J Haematol; 1989 May; 72(1):16-20. PubMed ID: 2736239
[TBL] [Abstract][Full Text] [Related]
11. Treatment with lisinopril normalizes serum concentrations of procollagen type III amino-terminal peptide in patients with essential hypertension.
Laviades C; Mayor G; Díez J
Am J Hypertens; 1994 Jan; 7(1):52-8. PubMed ID: 8136111
[TBL] [Abstract][Full Text] [Related]
12. [Serum aminoterminal procollagen type-III peptide in the diagnosis of chronic hepatopathies].
Solís-Herruzo JA; Morillas JD; Vargas J; Colina F; Castellano G; Muñoz Yagüe T; Estenoz J
Med Clin (Barc); 1992 May; 99(1):1-5. PubMed ID: 1602891
[TBL] [Abstract][Full Text] [Related]
13. N-terminal propeptide of type-III procollagen concentrations in the cord blood: an index of newborn maturity.
Yunoki H; Yagi H; Nagashima K; Noji T; Miyake H; Kuroume T
Biol Neonate; 1990; 58(5):264-70. PubMed ID: 2076445
[TBL] [Abstract][Full Text] [Related]
14. [Determination of procollagen type III aminopropeptide by a solid phase method using antibodies conjugated with peroxidase or protein A labelled with radioactive iodine].
Planutis KS; Morozevich GE; Berman AE
Vopr Med Khim; 1992; 38(2):57-9. PubMed ID: 1413636
[TBL] [Abstract][Full Text] [Related]
15. Fractionation of the liver membrane lipoprotein (LSP) and characterisation of its antigenic determinants by autoantibodies and a heterologous anti-serum.
Manns M; Meyer zum Büschenfelde KH
Gut; 1982 Jan; 23(1):14-20. PubMed ID: 6173289
[TBL] [Abstract][Full Text] [Related]
16. Cartilage fucoproteins with sites for cross-linking by transglutaminase.
Bowness JM
Biochem Cell Biol; 1987 Apr; 65(4):280-5. PubMed ID: 2886140
[TBL] [Abstract][Full Text] [Related]
17. An immunohistochemical and serum ELISA study of type I and III procollagen aminopropeptides in primary biliary cirrhosis.
Davis BH; Madri JA
Am J Pathol; 1987 Aug; 128(2):265-75. PubMed ID: 3303951
[TBL] [Abstract][Full Text] [Related]
18. Relationship of serum levels of pro-type I collagen peptide, pro-type III collagen peptide and type IV 7S collagen with cervical maturation.
Kanayama N; Terao T
Gynecol Obstet Invest; 1992; 34(1):24-6. PubMed ID: 1526527
[TBL] [Abstract][Full Text] [Related]
19. [Procollagen III and laminin in chronic viral hepatopathies].
Montalto G; Soresi M; Aragona F; Tripi S; Carroccio A; Anastasi G; Magliarisi C; Barresi E; Notarbartolo A
Presse Med; 1996 Jan; 25(2):59-62. PubMed ID: 8745719
[TBL] [Abstract][Full Text] [Related]
20. Procollagen-III peptide and chronic viral C hepatitis.
Jeffers LJ; Coelho-Little ME; Cheinquer H; Vargas C; Civantos F; Alvarez L; Reddy KR; Parker T; de Medina M; Li X
Am J Gastroenterol; 1995 Sep; 90(9):1437-40. PubMed ID: 7661165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
